Selected research
Industry Research
Fosaprepitant Dimeglumine Industry Research Report 2026
Market perspective
The global Fosaprepitant Dimeglumine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fosaprepitant Dimeglumine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fosaprepitant Dimeglumine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fosaprepitant Dimeglumine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fosaprepitant Dimeglumine include Aark Pharmaceuticals, Amneal, Apotex, Torrent Pharmaceuticals, Aosaikang Pharmaceutical, Fresenius Kabi, Hansoh Pharma, Jiuyuan Gene Engineering and Luoxin Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fosaprepitant Dimeglumine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fosaprepitant Dimeglumine Market by Company
Aark Pharmaceuticals
Amneal
Apotex
Torrent Pharmaceuticals
Aosaikang Pharmaceutical
Fresenius Kabi
Hansoh Pharma
Jiuyuan Gene Engineering
Luoxin Pharmaceutical
Merck
Qilu Pharmaceutical
Yichang Humanwell Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Fosaprepitant Dimeglumine Segment by Type
Original Drug
Generic Drug
Fosaprepitant Dimeglumine Segment by Application
Hospital
Specialty Clinic
Fosaprepitant Dimeglumine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosaprepitant Dimeglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosaprepitant Dimeglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosaprepitant Dimeglumine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fosaprepitant Dimeglumine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fosaprepitant Dimeglumine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fosaprepitant Dimeglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital
- Specialty Clinic
Companies covered
- Aark Pharmaceuticals
- Amneal
- Apotex
- Torrent Pharmaceuticals
- Aosaikang Pharmaceutical
- Fresenius Kabi
- Hansoh Pharma
- Jiuyuan Gene Engineering
- Luoxin Pharmaceutical
- Merck
- Qilu Pharmaceutical
- Yichang Humanwell Pharmaceutical
- Chia Tai Tianqing Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fosaprepitant Dimeglumine Market Size (2021-2032)
- 2.2.2 Global Fosaprepitant Dimeglumine Sales (2021-2032)
- 2.2.3 Global Fosaprepitant Dimeglumine Market Average Price (2021-2032)
- 2.3 Fosaprepitant Dimeglumine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Original Drug
- 2.3.3 Generic Drug
- 2.4 Fosaprepitant Dimeglumine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Specialty Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fosaprepitant Dimeglumine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fosaprepitant Dimeglumine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Fosaprepitant Dimeglumine Revenue of Manufacturers (2021-2026)
- 3.4 Global Fosaprepitant Dimeglumine Average Price by Manufacturers (2021-2026)
- 3.5 Global Fosaprepitant Dimeglumine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fosaprepitant Dimeglumine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fosaprepitant Dimeglumine, Product Type & Application
- 3.8 Global Manufacturers of Fosaprepitant Dimeglumine, Established Date
- 3.9 Global Fosaprepitant Dimeglumine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aark Pharmaceuticals
- 4.1.1 Aark Pharmaceuticals Company Information
- 4.1.2 Aark Pharmaceuticals Business Overview
- 4.1.3 Aark Pharmaceuticals Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aark Pharmaceuticals Fosaprepitant Dimeglumine Product Portfolio
- 4.1.5 Aark Pharmaceuticals Recent Developments
- 4.2 Amneal
- 4.2.1 Amneal Company Information
- 4.2.2 Amneal Business Overview
- 4.2.3 Amneal Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amneal Fosaprepitant Dimeglumine Product Portfolio
- 4.2.5 Amneal Recent Developments
- 4.3 Apotex
- 4.3.1 Apotex Company Information
- 4.3.2 Apotex Business Overview
- 4.3.3 Apotex Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Apotex Fosaprepitant Dimeglumine Product Portfolio
- 4.3.5 Apotex Recent Developments
- 4.4 Torrent Pharmaceuticals
- 4.4.1 Torrent Pharmaceuticals Company Information
- 4.4.2 Torrent Pharmaceuticals Business Overview
- 4.4.3 Torrent Pharmaceuticals Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Torrent Pharmaceuticals Fosaprepitant Dimeglumine Product Portfolio
- 4.4.5 Torrent Pharmaceuticals Recent Developments
- 4.5 Aosaikang Pharmaceutical
- 4.5.1 Aosaikang Pharmaceutical Company Information
- 4.5.2 Aosaikang Pharmaceutical Business Overview
- 4.5.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine Product Portfolio
- 4.5.5 Aosaikang Pharmaceutical Recent Developments
- 4.6 Fresenius Kabi
- 4.6.1 Fresenius Kabi Company Information
- 4.6.2 Fresenius Kabi Business Overview
- 4.6.3 Fresenius Kabi Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fresenius Kabi Fosaprepitant Dimeglumine Product Portfolio
- 4.6.5 Fresenius Kabi Recent Developments
- 4.7 Hansoh Pharma
- 4.7.1 Hansoh Pharma Company Information
- 4.7.2 Hansoh Pharma Business Overview
- 4.7.3 Hansoh Pharma Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hansoh Pharma Fosaprepitant Dimeglumine Product Portfolio
- 4.7.5 Hansoh Pharma Recent Developments
- 4.8 Jiuyuan Gene Engineering
- 4.8.1 Jiuyuan Gene Engineering Company Information
- 4.8.2 Jiuyuan Gene Engineering Business Overview
- 4.8.3 Jiuyuan Gene Engineering Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiuyuan Gene Engineering Fosaprepitant Dimeglumine Product Portfolio
- 4.8.5 Jiuyuan Gene Engineering Recent Developments
- 4.9 Luoxin Pharmaceutical
- 4.9.1 Luoxin Pharmaceutical Company Information
- 4.9.2 Luoxin Pharmaceutical Business Overview
- 4.9.3 Luoxin Pharmaceutical Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Luoxin Pharmaceutical Fosaprepitant Dimeglumine Product Portfolio
- 4.9.5 Luoxin Pharmaceutical Recent Developments
- 4.10 Merck
- 4.10.1 Merck Company Information
- 4.10.2 Merck Business Overview
- 4.10.3 Merck Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Merck Fosaprepitant Dimeglumine Product Portfolio
- 4.10.5 Merck Recent Developments
- 4.11 Qilu Pharmaceutical
- 4.11.1 Qilu Pharmaceutical Company Information
- 4.11.2 Qilu Pharmaceutical Business Overview
- 4.11.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Qilu Pharmaceutical Fosaprepitant Dimeglumine Product Portfolio
- 4.11.5 Qilu Pharmaceutical Recent Developments
- 4.12 Yichang Humanwell Pharmaceutical
- 4.12.1 Yichang Humanwell Pharmaceutical Company Information
- 4.12.2 Yichang Humanwell Pharmaceutical Business Overview
- 4.12.3 Yichang Humanwell Pharmaceutical Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yichang Humanwell Pharmaceutical Fosaprepitant Dimeglumine Product Portfolio
- 4.12.5 Yichang Humanwell Pharmaceutical Recent Developments
- 4.13 Chia Tai Tianqing Pharmaceutical
- 4.13.1 Chia Tai Tianqing Pharmaceutical Company Information
- 4.13.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 4.13.3 Chia Tai Tianqing Pharmaceutical Fosaprepitant Dimeglumine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chia Tai Tianqing Pharmaceutical Fosaprepitant Dimeglumine Product Portfolio
- 4.13.5 Chia Tai Tianqing Pharmaceutical Recent Developments
5 Global Fosaprepitant Dimeglumine Market Scenario by Region
- 5.1 Global Fosaprepitant Dimeglumine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fosaprepitant Dimeglumine Sales by Region: 2021-2032
- 5.2.1 Global Fosaprepitant Dimeglumine Sales by Region: 2021-2026
- 5.2.2 Global Fosaprepitant Dimeglumine Sales by Region: 2027-2032
- 5.3 Global Fosaprepitant Dimeglumine Revenue by Region: 2021-2032
- 5.3.1 Global Fosaprepitant Dimeglumine Revenue by Region: 2021-2026
- 5.3.2 Global Fosaprepitant Dimeglumine Revenue by Region: 2027-2032
- 5.4 North America Fosaprepitant Dimeglumine Market Facts & Figures by Country
- 5.4.1 North America Fosaprepitant Dimeglumine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fosaprepitant Dimeglumine Sales by Country (2021-2032)
- 5.4.3 North America Fosaprepitant Dimeglumine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fosaprepitant Dimeglumine Market Facts & Figures by Country
- 5.5.1 Europe Fosaprepitant Dimeglumine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fosaprepitant Dimeglumine Sales by Country (2021-2032)
- 5.5.3 Europe Fosaprepitant Dimeglumine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fosaprepitant Dimeglumine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fosaprepitant Dimeglumine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fosaprepitant Dimeglumine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fosaprepitant Dimeglumine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fosaprepitant Dimeglumine Market Facts & Figures by Country
- 5.7.1 South America Fosaprepitant Dimeglumine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fosaprepitant Dimeglumine Sales by Country (2021-2032)
- 5.7.3 South America Fosaprepitant Dimeglumine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fosaprepitant Dimeglumine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fosaprepitant Dimeglumine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fosaprepitant Dimeglumine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fosaprepitant Dimeglumine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fosaprepitant Dimeglumine Sales by Type (2021-2032)
- 6.1.1 Global Fosaprepitant Dimeglumine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Fosaprepitant Dimeglumine Sales Market Share by Type (2021-2032)
- 6.2 Global Fosaprepitant Dimeglumine Revenue by Type (2021-2032)
- 6.2.1 Global Fosaprepitant Dimeglumine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fosaprepitant Dimeglumine Revenue Market Share by Type (2021-2032)
- 6.3 Global Fosaprepitant Dimeglumine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fosaprepitant Dimeglumine Sales by Application (2021-2032)
- 7.1.1 Global Fosaprepitant Dimeglumine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Fosaprepitant Dimeglumine Sales Market Share by Application (2021-2032)
- 7.2 Global Fosaprepitant Dimeglumine Revenue by Application (2021-2032)
- 7.2.1 Global Fosaprepitant Dimeglumine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fosaprepitant Dimeglumine Revenue Market Share by Application (2021-2032)
- 7.3 Global Fosaprepitant Dimeglumine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fosaprepitant Dimeglumine Value Chain Analysis
- 8.1.1 Fosaprepitant Dimeglumine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fosaprepitant Dimeglumine Production Mode & Process
- 8.2 Fosaprepitant Dimeglumine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fosaprepitant Dimeglumine Distributors
- 8.2.3 Fosaprepitant Dimeglumine Customers
9 Global Fosaprepitant Dimeglumine Analyzing Market Dynamics
- 9.1 Fosaprepitant Dimeglumine Industry Trends
- 9.2 Fosaprepitant Dimeglumine Industry Drivers
- 9.3 Fosaprepitant Dimeglumine Industry Opportunities and Challenges
- 9.4 Fosaprepitant Dimeglumine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst